← Back to Clinical Trials
Recruiting NCT06629038

NCT06629038 Estimating Jaw, Neck, and Shoulder Range of Motion Using an AI Model

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06629038
Status Recruiting
Phase —
Sponsor National Taiwan University Hospital
Condition Oral Cancer
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2024-12-05
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
observation alone

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2024-12-05 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational study aims to develop an AI-based system for tracking mandibular and shoulder movements using deep learning techniques. It will compare AI-generated pose estimations with gold standard measurements to assess accuracy, particularly in patients with functional impairments from oral cancer treatment, such as trismus, spinal accessory nerve dysfunction, neck dystonia, and radiation fibrosis.

Eligibility Criteria

Inclusion Criteria: * Healthy adults without a history of head, neck or shoulder injury or surgery, and without HNC-related radiotherapy or chemoradiotherapy * Oral cancer patients with trismus, clinical signs of neck or shoulder joint impairment after oral cancer surgery or radiotherapy * Age between 20 and 65 years Exclusion Criteria: * Could not communicate * Had any disorder that could influence movement performance

Contact & Investigator

Central Contact

Yueh-Hsia Chen, PhD

✉ yuehhsiachen@ntu.edu.tw

📞 +886 921435981

Principal Investigator

Yueh-Hsia Chen, PhD

PRINCIPAL INVESTIGATOR

School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University

Frequently Asked Questions

Who can join the NCT06629038 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 65 Years, studying Oral Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06629038 currently recruiting?

Yes, NCT06629038 is actively recruiting participants. Contact the research team at yuehhsiachen@ntu.edu.tw for enrollment information.

Where is the NCT06629038 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT06629038 clinical trial?

NCT06629038 is sponsored by National Taiwan University Hospital. The principal investigator is Yueh-Hsia Chen, PhD at School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology